BioTech Tools S.A.: Clinical Trials

7 trials sponsored by BioTech Tools S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 4 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 13Completed 3
Phase 31Completed 1

Follow BioTech Tools S.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Placebo solution, gpASIT+TM - Hay Fever
Phase 3CompletedBioTech Tools S.A.5542015-12-012018-10-11
Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM
gpASIT+TM - Hay Fever
Phase 2CompletedBioTech Tools S.A.612013-08-012014-06-06
Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant
gpASIT+TM, gpASIT+TM + adjuvant - Hay Fever
Phase 2CompletedBioTech Tools S.A.242011-11-012014-05-26
Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis
gpASIT+TM, Placebo - Grass Pollen Allergy, Hay Fever
Phase 2CompletedBioTech Tools S.A.2022010-12-012014-05-26
Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis
gpASIT+TM, gpAST+TM/adjuvant, Placebo solution - Seasonal Allergic Rhinoconjunctivitis
Phase 1CompletedBioTech Tools S.A.272010-03-012011-03-01
Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis
gpASIT+TM, Placebo - Seasonal Allergic Rhinoconjunctivitis
Phase 1 / Phase 2CompletedBioTech Tools S.A.542009-02-012011-11-17
Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis
gpASIT+TM - Seasonal Allergic Rhinoconjunctivitis
Phase 1CompletedBioTech Tools S.A.82008-12-012014-05-26

Conditions studied

Rhinitis, Allergic, Seasonal (5)  ·  Hypersensitivity (1)  ·  Immune System Diseases (1)

Interventions

Adjuvants, Pharmaceutic (1)

Countries

Belgium (6)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Luxembourg (1)  ·  Spain (1)

Top investigators

Bettina Hauswald, MD (1)  ·  Bruno Lebeaupin, MD (1)  ·  Catherine Mbasoa, MD (1)  ·  Charles Pilette, MD (1)  ·  Christoph Verhoye, MD (1)  ·  Claus Bachert, MD (1)  ·  Claus Bachert, Professor (1)  ·  Didier Ebo, MD (1)  ·  Enrico Iemoli, MD (1)

Results publications

PMID 30844425